Pierluigi Bove
University of Rome Tor Vergata, Ospedale San Carlo, Policlinico Tor Vergata
Papers
32
Total Citations
803
H-Index
15
About
Pierluigi Bove is a leading urologic surgeon whose research has fundamentally advanced the surgical management of kidney and prostate cancers. His primary focus lies in optimizing partial nephrectomy—a kidney-sparing procedure—where he has been instrumental in the debate over clamping the renal artery during surgery. Through landmark studies like the multicenter CLOCK trial (103 citations) and the RECORd 2 Project (131 citations), Bove has rigorously compared on-clamp versus off-clamp techniques, providing critical evidence on functional outcomes and complication risks. His work has helped shape best practices for robotic and laparoscopic partial nephrectomy, with his systematic review and meta-analysis on the topic (53 citations) serving as a key reference. Beyond nephrectomy, Bove has explored 3D versus 2D laparoscopy for prostate cancer (53 citations) and pioneered telesurgery (73 citations), demonstrating early leadership in remote surgical guidance. His contributions to developing nomograms for predicting postoperative complications (29 citations) further underscore his commitment to improving patient outcomes. With over 500 cumulative citations across his most influential papers, Bove’s research continues to guide surgeons in balancing oncologic control with renal function preservation.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency?22 citations · 2020